Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease

Overview

Journal Nutrients

Date 2016 Jan 20

PMID 26784223

Citations 35

Authors

Jing Sun

Xiao Shen

Yi Li

Zhen Guo

Weiming Zhu

Lugen Zuo

Jie Zhao

Lili Gu

Jianfeng Gong

Jieshou Li

Affiliations

Soon will be listed here.

Abstract

Recently, numerous studies have shown that disruption of the mucus barrier plays an important role in the exacerbation of inflammatory bowel disease, particularly in ulcerative colitis. Alterations in the mucus barrier are well supported by published data and are widely accepted. The use of fluorescence in situ hybridization and Carnoy's fixation has revealed the importance of the mucus barrier in maintaining a mutualistic relationship between host and bacteria. Studies have raised the possibility that modulation of the mucus barrier may provide therapies for the disease, using agents such as short-chain fatty acids, prebiotics and probiotics. This review describes changes in the mucus barrier of patients with inflammatory bowel disease and in animal models of the disease. We also review the involvement of the mucus barrier in the exacerbation of the disease and explore the therapeutic potential of modifying the mucus barrier with short-chain fatty acids, prebiotics, probiotics, fatty acid synthase, H₂S, neutrophil elastase inhibitor and phophatidyl choline.

Citing Articles

MIIST305 mitigates gastrointestinal acute radiation syndrome injury and ameliorates radiation-induced gut microbiome dysbiosis.

Mitra D, Armijo G, Ober E, Baker S, Turner H, Broustas C Gut Microbes. 2025; 17(1):2458189.

PMID: 39930324 PMC: 11817531. DOI: 10.1080/19490976.2025.2458189.

Association between plant-based dietary index and disease severity in patients with ulcerative colitis: a cross-sectional study.

Nikniaz Z, Mahdavi R, Bakhtiari Z, Masnadi Shirazi K BMC Gastroenterol. 2024; 24(1):328.

PMID: 39350062 PMC: 11440883. DOI: 10.1186/s12876-024-03392-8.

Extract Protects Lipopolysaccharide-Induced Intestinal Inflammation in Mice via Promoting M2 Macrophage Polarization.

Wu H, Guo M, Zhao L, Zhang J, He J, Xu A Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204128 PMC: 11357656. DOI: 10.3390/ph17081023.

Gastroprotective Effect of 2,3-Dimethylquinoxaline Against Indomethacin-Induced Gastric Ulcer in Rat.

Alfadil A J Inflamm Res. 2024; 17:1983-1994.

PMID: 38566982 PMC: 10986627. DOI: 10.2147/JIR.S453425.

Using a human colonoid-derived monolayer to study bacteriophage translocation.

Le H, Lubian A, Bowring B, van der Poorten D, Iredell J, George J Gut Microbes. 2024; 16(1):2331520.

PMID: 38517357 PMC: 10962583. DOI: 10.1080/19490976.2024.2331520.

References

Shimotoyodome A, Meguro S, Hase T, Tokimitsu I, Sakata T . Short chain fatty acids but not lactate or succinate stimulate mucus release in the rat colon. Comp Biochem Physiol A Mol Integr Physiol. 2000; 125(4):525-31. DOI: 10.1016/s1095-6433(00)00183-5. View

SMIRNOVA M, Birchall J, Pearson J . TNF-alpha in the regulation of MUC5AC secretion: some aspects of cytokine-induced mucin hypersecretion on the in vitro model. Cytokine. 2000; 12(11):1732-6. DOI: 10.1006/cyto.2000.0763. View

Campieri M, Gionchetti P . Bacteria as the cause of ulcerative colitis. Gut. 2000; 48(1):132-5. PMC: 1728175. DOI: 10.1136/gut.48.1.132. View

Ross Z, OGara E, Hill D, Sleightholme H, Maslin D . Antimicrobial properties of garlic oil against human enteric bacteria: evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder. Appl Environ Microbiol. 2001; 67(1):475-80. PMC: 92605. DOI: 10.1128/AEM.67.1.475-480.2001. View

Ishibashi N, Yamazaki S . Probiotics and safety. Am J Clin Nutr. 2001; 73(2 Suppl):465S-470S. DOI: 10.1093/ajcn/73.2.465s. View

SMIRNOVA M, Kiselev S, Birchall J, Pearson J . Up-regulation of mucin secretion in HT29-MTX cells by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-6. Eur Cytokine Netw. 2001; 12(1):119-25. View

Atuma C, Strugala V, Allen A, Holm L . The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol. 2001; 280(5):G922-9. DOI: 10.1152/ajpgi.2001.280.5.G922. View

Nadel J . Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir Res. 2001; 2(2):85-9. PMC: 59573. DOI: 10.1186/rr43. View

Whittaker L, Niu N, Stoddard A, Flavell R, Ray A, Homer R . Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol. 2002; 27(5):593-602. DOI: 10.1165/rcmb.4838. View

10.

Tarrerias A, Millecamps M, Alloui A, Beaughard C, Kemeny J, Bourdu S . Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats. Pain. 2002; 100(1-2):91-7. DOI: 10.1016/s0304-3959(02)00234-8. View

11.

Godl K, Johansson M, Lidell M, Morgelin M, Karlsson H, Olson F . The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J Biol Chem. 2002; 277(49):47248-56. DOI: 10.1074/jbc.M208483200. View

12.

Willemsen L, Koetsier M, van Deventer S, van Tol E . Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut. 2003; 52(10):1442-7. PMC: 1773837. DOI: 10.1136/gut.52.10.1442. View

13.

Clayburgh D, Shen L, Turner J . A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest. 2004; 84(3):282-91. DOI: 10.1038/labinvest.3700050. View

14.

Ehehalt R, Jochims C, Lehmann W, Erben G, Staffer S, Reininger C . Evidence of luminal phosphatidylcholine secretion in rat ileum. Biochim Biophys Acta. 2004; 1682(1-3):63-71. DOI: 10.1016/j.bbalip.2004.01.009. View

15.

Sellers L, Allen A, Morris E . Mucus glycoprotein gels. Role of glycoprotein polymeric structure and carbohydrate side-chains in gel-formation. Carbohydr Res. 1988; 178:93-110. DOI: 10.1016/0008-6215(88)80104-6. View

16.

Paulson J, Colley K . Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem. 1989; 264(30):17615-8. View

17.

Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S . Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut. 2006; 56(3):343-50. PMC: 1856798. DOI: 10.1136/gut.2006.098160. View

18.

Wallace J, Vong L, McKnight W, Dicay M, Martin G . Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology. 2009; 137(2):569-78, 578.e1. DOI: 10.1053/j.gastro.2009.04.012. View

19.

Barnes M, Powrie F . Regulatory T cells reinforce intestinal homeostasis. Immunity. 2009; 31(3):401-11. DOI: 10.1016/j.immuni.2009.08.011. View

20.

Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, Partanen P . Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci U S A. 2009; 106(40):17193-8. PMC: 2746127. DOI: 10.1073/pnas.0908876106. View